ROSEN, SKILLED INVESTOR COUNSEL, Encourages Aurinia Pharmaceuticals Inc. Investors to Inquire About Securities Class Action Investigation - AUPH Pharmaceutical Investing
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Aurinia Pharmaceuticals Inc. with Losses of $100,000 to Contact the Firm Pharmaceutical Investing
Now Available Over the Counter, LASTACAFT® Provides Eye Allergy Itch Relief in Minutes that Lasts Through 16 Hours Pharmaceutical Investing
AbbVie and Scripps Research Announce Collaboration to Develop Antiviral Treatments for COVID-19 Pharmaceutical Investing
Numinus to Participate in Maxim's 2022 Virtual Growth Conference on March 28-30, 2022 Pharmaceutical Investing
Merck Announces KEYLYNK-010 Trial Evaluating KEYTRUDA® in Combination with LYNPARZA® in Patients with Metastatic Castration-Resistant Prostate Cancer to Stop for Futility Life Science Investing
Bristol Myers Squibb and Nektar Announce Update on Phase 3 PIVOT IO-001 Trial Evaluating Bempegaldesleukin in Combination with Opdivo in Previously Untreated Unresectable or Metastatic Melanoma Pharmaceutical Investing
IDEAYA and Pfizer Expand Clinical Trial Collaboration and Supply Agreements for Evaluation of Darovasertib and Crizotinib Combination in Metastatic Uveal Melanoma and Additional cMET-Driven Tumors Life Science Investing
AUPH Investor Alert: ROSEN, A Top Ranked Law Firm, Encourages Aurinia Pharmaceuticals Inc. Investors with Losses Exceeding $100K to Inquire About Securities Class Action Investigation - AUPH Pharmaceutical Investing
